About ImmunoVision
ImmunoVision is a company based in Springdale (United States) founded in 1995 was acquired by Erba Diagnostics in September 2010. ImmunoVision offers products and services including Autoimmune Purified Antigens, Autoimmune Monoclonal Antibodies, Microtiter Plate Coating, Custom Purification, and Assay Development. ImmunoVision operates in a competitive market with competitors including Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.
- Headquarter Springdale, United States
- SectorsHealthcare
- Email••••••••
- Website immunovision.com
- Social LinkedIn
- Acquired by Erba Diagnostics (Sep 2010)
- Investors
- Acquired byErba Diagnostics
(Sep 2010)
Products & Services of ImmunoVision
ImmunoVision offers a comprehensive portfolio of products and services, including Autoimmune Purified Antigens, Autoimmune Monoclonal Antibodies, Microtiter Plate Coating, Custom Purification, and Assay Development.
Purified antigens for autoimmune disease testing and research
Monoclonal antibodies used in autoimmune diagnostics
Coating service for immunoassay development
Purification services for proteins and antibodies
Development of immunoassays for research applications
Investors in ImmunoVision
ImmunoVision has secured backing from 1 investor. Prominent investors backing the company include Erba Diagnostics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diagnostic assays and instruments are developed for medical diagnostics. | 2001 | erbadiagnostics.com | Miami, United States |
Investor details for ImmunoVision
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ImmunoVision
2 dated milestones of ImmunoVision across 15 years, from founding to its latest funding, stage changes and deals.
- Founded ImmunoVision is founded.
- Exit Acquired by Erba Diagnostics.
Competitors of ImmunoVision
ImmunoVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Meridian Bioscience, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| caymanchem.com | 1980 | Ann Arbor, United States | – | 309 | Bioreagents and assay kits are developed, with preclinical services provided. | |
| abclonal.com | 2006 | Woburn, United States | $281.25M | – | Developer of protein and peptide reagents and kits for cell and molecular biology research | |
| seracare.com | 1984 | Milford, United States | – | – | Provider of biological materials/products that help optimize diagnostic performance, reliability and repeatability |
Detailed competitors of ImmunoVision
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to ImmunoVision
10 companies that operate in the same segment as ImmunoVision (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ImmunoVision
ImmunoVision was founded in 1995.
ImmunoVision is headquartered in Springdale, United States. It is registered at Springdale, Arkansas, United States.
ImmunoVision was founded in 1995 and is based in Springdale, United States. Bioreagents are produced and supplied to the diagnostic sector, focusing on autoimmune applications such as purified antigens, monoclonal antibodies, polyclonal antibodies, ENA Ouchterlony components, extracts, and acetone tissue powders. For infectious diseases, purified antigens, monoclonal antibodies, and polyclonal antibodies are also offered. Operations are conducted as a subsidiary of ERBA Diagnostics Inc.
ImmunoVision's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
ImmunoVision offers Autoimmune Purified Antigens, Autoimmune Monoclonal Antibodies, Microtiter Plate Coating, Custom Purification, and Assay Development.
ImmunoVision has 1 investor. Key investors include Erba Diagnostics.
Yes. ImmunoVision was acquired by Erba Diagnostics in September 2010.